EUVIMEDEUVIMED entdecken
Open Access

VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71

Wen-Sheng Hsieh, Chiao-Hsuan Chao iD, Chun-Yu Shen, Dayna Cheng, Sheng-Wen Huang, Ya-Fang Wang, Chien-Chin Chen, Shun-Hua Chen, Li-Jin Hsu iD, Jen-Ren Wang iD

Journal of Virology · 2024

DOI: 10.1128/jvi.01558-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Wen-Sheng Hsieh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Enterovirus A, Human, Enterovirus Infections, Capsid Proteins, RNA-Dependent RNA Polymerase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Science and Technology Council (NSTC), National Health Research Institutes (NHRI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterovirus A71 (EV-A71) can induce severe neurological complications and even fatal encephalitis in children, and it has caused several large outbreaks in Taiwan since 1998. We previously generated VP1 codon-deoptimized (VP1-CD) reverse genetics (rg) EV-A71 viruses (rgEV-A71s) that harbor a high-fidelity (HF) 3D polymerase. These VP1-CD-HF rgEV-A71s showed lower replication kinetics in vitro and decreased virulence in an Institute of Cancer Research (ICR) mouse model of EV-A71 infection, while still retaining their antigenicity in comparison to the wild-type virus. In this study, we aimed to further investigate the humoral and cellular immune responses elicited by VP1-CD-HF rgEV-A71s to assess the potential efficacy of these EV-A71 vaccine candidates. Following intraperitoneal (i.p.) injection of VP1-CD-HF rgEV-A71s in mice, we observed a robust induction of EV-A71-specific neutralizing IgG antibodies in the antisera after 21 days. Splenocytes isolated from VP1-CD-HF rgEV-A71s-immunized mice exhibited enhanced proliferative activities and cytokine production (IL-2, IFN-γ, IL-4, IL-6, and TNF-α) upon re-stimulation with VP1-CD-HF rgEV-A71, as compared to control mice treated with adjuvant only. Importantly, administration of antisera from VP1-CD-HF rgEV-A71s-immunized mice protected against lethal EV-A71 challenge in neonatal mice. These findings highlight that our generated VP1-CD-HF rgEV-A71 viruses are capable of inducing both cellular and humoral immune responses, supporting their potential as next-generation EV-A71 vaccines for combating EV-A71 infection. IMPORTANCE EV-A71 can cause severe neurological diseases and cause death in young children. Here, we report the development of synthetic rgEV-A71s with the combination of codon deoptimization and high-fidelity (HF) substitutions that generate genetically stable reverse genetics (rg) viruses as potential attenuated vaccine candidates. Our work provides insight into the development of low-virulence candidate vaccines through a series of viral genetic editing for maintaining antigenicity and genome stability and suggests a strategy for the development of an innovative next-generation vaccine against EV-A71.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterovirus A, HumanEnterovirus InfectionsCapsid ProteinsRNA-Dependent RNA PolymeraseAnimalsMiceAntibodies, ViralCodonVaccines, AttenuatedImmunity, HumoralImmunity, CellularAntibodies, NeutralizingViral VaccinesMice, Inbred ICRMice, Inbred BALB C

Stichwörter der Autor:innen

codon-deoptimizationenterovirus A71high-fidelityreverse genetics virusvaccine

Substanzen

Antibodies, ViralCodonVaccines, AttenuatedCapsid ProteinsAntibodies, NeutralizingViral VaccinesRNA-Dependent RNA Polymerase

Autor:innen und Institutionen

  • Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • The Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Tainan, Taiwan.
  • Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.
  • Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.
  • Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.

ORCID-Profile: Chiao-Hsuan Chao, Li-Jin Hsu, Jen-Ren Wang

Förderung

  • National Science and Technology Council (NSTC)
  • National Health Research Institutes (NHRI)

Zitieren

APA

Hsieh, W. S., Chao, C. H., Shen, C. Y., Cheng, D., Huang, S. W., Wang, Y. F., Chen, C. C., Chen, S. H., Hsu, L. J., & Wang, J. R. (2024). VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71. Journal of Virology. https://doi.org/10.1128/jvi.01558-23

Vancouver

Hsieh WS, Chao CH, Shen CY, Cheng D, Huang SW, Wang YF, et al. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71. Journal of Virology. 2024. doi:10.1128/jvi.01558-23

BibTeX
@article{Hsieh2024,
  author = {Hsieh, Wen-Sheng and Chao, Chiao-Hsuan and Shen, Chun-Yu and Cheng, Dayna and Huang, Sheng-Wen and Wang, Ya-Fang and Chen, Chien-Chin and Chen, Shun-Hua and Hsu, Li-Jin and Wang, Jen-Ren},
  title = {VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01558-23}
}
Kostenlos starten →